Cite
Successful Management of Acquired Factor V Inhibitor by Monitoring Factor V Activity, Antigen, and Inhibitor Values during Immunosuppressive Therapy.
MLA
Mihara, Masahiro, et al. “Successful Management of Acquired Factor V Inhibitor by Monitoring Factor V Activity, Antigen, and Inhibitor Values during Immunosuppressive Therapy.” Acta Haematologica, vol. 143, no. 5, Sept. 2020, pp. 486–90. EBSCOhost, https://doi.org/10.1159/000502730.
APA
Mihara, M., Ogawa, Y., Nagasaka, M., Kobayashi, N., Shimizu, H., Shinozawa, K., Fukutake, K., Inoue, M., Murakami, M., & Handa, H. (2020). Successful Management of Acquired Factor V Inhibitor by Monitoring Factor V Activity, Antigen, and Inhibitor Values during Immunosuppressive Therapy. Acta Haematologica, 143(5), 486–490. https://doi.org/10.1159/000502730
Chicago
Mihara, Masahiro, Yoshiyuki Ogawa, Motoo Nagasaka, Nobuhiko Kobayashi, Hiroaki Shimizu, Keiko Shinozawa, Katsuyuki Fukutake, Madoka Inoue, Masami Murakami, and Hiroshi Handa. 2020. “Successful Management of Acquired Factor V Inhibitor by Monitoring Factor V Activity, Antigen, and Inhibitor Values during Immunosuppressive Therapy.” Acta Haematologica 143 (5): 486–90. doi:10.1159/000502730.